Feier Feng

642 total citations
26 papers, 446 citations indexed

About

Feier Feng is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Feier Feng has authored 26 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Genetics and 7 papers in Oncology. Recurrent topics in Feier Feng's work include Platelet Disorders and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Feier Feng is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Feier Feng collaborates with scholars based in China and Ethiopia. Feier Feng's co-authors include Xiao‐Jun Huang, Qianming Wang, Xiaolu Zhu, Lan‐Ping Xu, Kai‐Yan Liu, Xiaohui Zhang, Jiamin Zhang, Hai‐Xia Fu, Jiamin Zhang and Shiyuan Zhou and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Cancer.

In The Last Decade

Feier Feng

25 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feier Feng China	11	167	147	122	67	66	26	446
Feiyan Wang China	10	139 0.8×	140 1.0×	139 1.1×	54 0.8×	82 1.2×	28	400
Lixun Guan China	9	140 0.8×	140 1.0×	121 1.0×	58 0.9×	63 1.0×	33	341
Atsushi Shinagawa Japan	13	208 1.2×	112 0.8×	142 1.2×	144 2.1×	55 0.8×	39	446
Luigi De Marco Italy	10	224 1.3×	167 1.1×	84 0.7×	73 1.1×	67 1.0×	13	430
Jacopo Olivieri Italy	11	134 0.8×	81 0.6×	75 0.6×	74 1.1×	56 0.8×	24	374
Bashar Dabbas United States	9	221 1.3×	124 0.8×	211 1.7×	92 1.4×	58 0.9×	22	559
Stephen Lim United States	11	129 0.8×	187 1.3×	142 1.2×	172 2.6×	42 0.6×	50	558
Yizhuo Zhang China	14	183 1.1×	67 0.5×	221 1.8×	135 2.0×	101 1.5×	47	472
Mike Keeney Canada	8	205 1.2×	164 1.1×	153 1.3×	153 2.3×	173 2.6×	13	516
Norihiro Awaya Japan	12	204 1.2×	122 0.8×	203 1.7×	120 1.8×	90 1.4×	26	474

Countries citing papers authored by Feier Feng

Since Specialization

Citations

This map shows the geographic impact of Feier Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feier Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feier Feng more than expected).

Fields of papers citing papers by Feier Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feier Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feier Feng. The network helps show where Feier Feng may publish in the future.

Co-authorship network of co-authors of Feier Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Feier Feng. A scholar is included among the top collaborators of Feier Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feier Feng. Feier Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yanfei, Lingyan Ping, Yuqin Song, et al.. (2024). Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial. BMC Medicine. 22(1). 107–107. 2 indexed citations

Deng, Lijuan, Lingyan Ping, Yunfei Shi, et al.. (2024). Germline variants of DNA repair and immune genes in lymphoma from lymphoma‐cancer families. International Journal of Cancer. 155(1). 93–103. 2 indexed citations

Liu, Jiaxin, Yunfei Hu, Yanfei Liu, et al.. (2023). Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China. Frontiers in Oncology. 13. 1264723–1264723.

Ying, Zhitao, Yan Xie, Wen Zheng, et al.. (2022). Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin’s lymphoma: 2-year results of a phase 1 trial. Bone Marrow Transplantation. 58(3). 288–294. 5 indexed citations

Wang, Xing, Ning Ding, Lan Mi, et al.. (2021). The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma. Cancers. 13(17). 4249–4249. 23 indexed citations

Liu, Weiping, Meng Wu, Yan Xie, et al.. (2020). Autologous hematopoietic stem cell transplantation with inadequate stem cell dose in patients with non-Hodgkin lymphoma. Leukemia & lymphoma. 62(2). 323–329. 3 indexed citations

Wang, Min, Ru Feng, Jiamin Zhang, et al.. (2019). Dysregulated megakaryocyte distribution associated with nestin+ mesenchymal stem cells in immune thrombocytopenia. Blood Advances. 3(9). 1416–1428. 25 indexed citations

He, Yun, Linlin Xu, Feier Feng, et al.. (2018). Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF‐κB/SMAD pathway in patients with immune thrombocytopenia. British Journal of Haematology. 180(3). 395–411. 39 indexed citations

Xu, Linlin, Hai‐Xia Fu, Jiamin Zhang, et al.. (2017). Impaired Function of Bone Marrow Mesenchymal Stem Cells from Immune Thrombocytopenia Patients in Inducing Regulatory Dendritic Cell Differentiation Through the Notch-1/Jagged-1 Signaling Pathway. Stem Cells and Development. 26(22). 1648–1661. 36 indexed citations

10.

Feng, Feier, Ru Feng, Min Wang, et al.. (2017). Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial. The Lancet Haematology. 4(10). e487–e496. 39 indexed citations

11.

Zhang, Xiaohui, Shiyuan Zhou, Ru Feng, et al.. (2016). Increased prostacyclin levels inhibit the aggregation and activation of platelets via the PI3K–AKT pathway in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Thrombosis Research. 139. 1–9. 8 indexed citations

12.

Zhang, Xiaohui, Feier Feng, Wei Han, et al.. (2016). High-dose corticosteroid associated with catheter-related thrombosis after allogeneic hematopoietic stem cell transplantation. Thrombosis Research. 144. 6–11. 3 indexed citations

13.

Zhang, Jiamin, Shiyuan Zhou, Yi Zhou, et al.. (2016). Adipose-Derived Mesenchymal Stem Cells (ADSCs) with the Potential to Ameliorate Platelet Recovery, Enhance Megakaryopoiesis, and Inhibit Apoptosis of Bone Marrow Cells in a Mouse Model of Radiation-Induced Thrombocytopenia. Cell Transplantation. 25(2). 261–273. 17 indexed citations

14.

Zhang, Xiaohui, Yun He, Ru Feng, et al.. (2015). Helicobacter pyloriinfection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study. Platelets. 27(3). 223–229. 6 indexed citations

15.

Zhang, Xiaohui, Xiaolu Zhu, Ting Niu, et al.. (2015). Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study. Thrombosis Research. 135(5). 835–840. 3 indexed citations

16.

Zhang, Xiaohui, Qianming Wang, Jiamin Zhang, et al.. (2015). Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT. Journal of Hematology & Oncology. 8(1). 116–116. 36 indexed citations

17.

Zhang, Xiaohui, Qian Jiang, Shenmiao Yang, et al.. (2015). ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in de novo adult B-cell acute lymphoblastic leukemia. Leukemia Research. 39(11). 1229–1238. 17 indexed citations

18.

Zhang, Xiaohui, Yi Zhou, Lan‐Ping Xu, et al.. (2014). Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 94(5). 837–845. 8 indexed citations

19.

Zhang, Jiamin, Shiyuan Zhou, Yi Zhou, et al.. (2014). Hepatocyte Growth Factor Gene-Modified Adipose-Derived Mesenchymal Stem Cells Ameliorate Radiation Induced Liver Damage in a Rat Model. PLoS ONE. 9(12). e114670–e114670. 53 indexed citations

20.

Zhang, Xiaohui, Yi Zhou, Shiyuan Zhou, et al.. (2014). IL-35 and Rapamycin Reduce Acute Graft-Versus-Host Disease Associated with Decreased Platelet Aggregation in a Mouse Model. Blood. 124(21). 3814–3814. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact